Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: A report from the Shanghai breast cancer survival study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Bao, Ping Ping ^a   Lu, Wei ^a   Cui, Yong ^b   Zheng, Ying ^a   Gu, Kai ^a   Chen, Zhi ^b   Zheng, Wei ^b   Shu, Xiao Ou ^b  

^a Shanghai Municipal Center for Disease Control and Prevention   (China)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; CANCER SURVIVOR; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG USE; FEMALE; GANODERMA LUCIDUM; GINSENG; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL WELLBEING; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL WELLBEING; WELLBEING;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PANAX; QUALITY OF LIFE; REISHI; TIME FACTORS; YOUNG ADULT;

EID: 84862657892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039343     Document Type: Article

References (35)

1. Parkin DM, Fernandez LM, (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12: S70-80.
2. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
3. De Angelis R, Tavilla A, Verdecchia A, Scoppa S, Hachey M, et al. (2009) Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015. Cancer 115: 1954-1966.
4. Trentham-Dietz A, Sprague BL, Klein R, Klein BE, Cruickshanks KJ, et al. (2008) Health-related quality of life before and after a breast cancer diagnosis. Breast Cancer Res Treat 109: 379-387.
5. Montazeri A, (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27: 32.
6. Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, et al. (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22: 3381-3388.
7. Boon H, Wong J, (2004) Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5: 2485-2501.
8. Carpenter CL, Ganz PA, Bernstein L, (2009) Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat 116: 387-396.
9. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA, (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23: 501-509.
10. Yun TK, (1999) Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci 889: 157-192.
11. Ernst E, (2005) The efficacy of herbal medicine-an overview. Fundam Clin Pharmacol 19: 405-409.
12. Sliva D, (2006) Ganoderma lucidum in cancer research. Leuk Res 30: 767-768.
13. Coleman CI, Hebert JH, Reddy P, (2003) The effects of Panax ginseng on quality of life. J Clin Pharm Ther 28: 5-15.
14. Ernst E, (2004) Prescribing herbal medications appropriately. J Fam Pract 53: 985-988.
15. Cui Y, Shu XO, Gao YT, Cai H, Tao MH, et al. (2006) Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 163: 645-653.
16. Vogler BK, Pittler MH, Ernst E, (1999) The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 55: 567-575.
17. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, et al. (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14: 1049-1055.
18. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP, et al. (2002) Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298: 603-612.
19. Jiang J, Slivova V, Sliva D, (2006) Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29: 695-703.
20. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D, (2005) Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330: 46-52.
21. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, et al. (2009) Soy food intake and breast cancer survival. Jama 302: 2437-2443.
22. Lu W, Cui Y, Zheng Y, Gu K, Cai H, et al. (2007) Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat 102: 201-210.
23. Chen X, Lu W, Zheng W, Gu K, Chen Z, et al. (2010) Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 122: 823-833.
24. Dorjgochoo T, Kallianpur A, Zheng Y, Gu K, Chen Z, et al. (2010) Impact of menopausal symptoms on quality of life 6 months after systemic breast cancer treatment: results from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 119: 725-735.
25. Grunau GL, Sheps S, Goldner EM, Ratner PA, (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59: 274-280.
26. (1998) International Classification of Disease, Ninth Revision, Clinical Modification. Washington, DC: US Government Printing Office.
27. Cui Y, Shu XO, Gao Y, Cai H, Wen W, et al. (2004) The long-term impact of medical and socio-demographic factors on the quality of life of breast cancer survivors among Chinese women. Breast Cancer Res Treat 87: 135-147.
28. Li L, Wang HM, Shen Y, (2003) Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 57: 259-263.
29. Zhou B, Chen K, Wang JF, Wu YY, Zheng WJ, et al. (2008) [Reliability and validity of a Short-Form Health Survey Scale (SF-36), Chinese version used in an elderly population of Zhejiang province in China]. Zhonghua Liu Xing Bing Xue Za Zhi 29: 1193-1198.
30. Yun TK, Lee YS, Lee YH, Kim SI, Yun HY, (2001) Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci 16.
31. Duda RB, Kang SS, Archer SY, Meng S, Hodin RA, (2001) American ginseng transcriptionally activates p21 mRNA in breast cancer cell lines. J Korean Med Sci 16.
32. Wang H, Peng D, Xie J, (2009) Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin Med 4: 20.
33. Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, et al. (2004) Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 85: 263-270.
34. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D, (2004) Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216.
35. Jiang J, Grieb B, Thyagarajan A, Sliva D, (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med 21: 577-584.